9th Circuit Panel Says Investors Don’t Show Falsity Of Drugmaker’s Statements
SAN FRANCISCO — A panel of the Ninth Circuit U.S. Court of Appeals in an unpublished opinion upheld a California federal judge’s dismissal of a putative class complaint brought by investors...To view the full article, register now.
Already a subscriber? Click here to view full article